Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: a meta-analysis and meta-regression
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Geographic difference in safety and efficacy of systemic chemotherapy for advanced gastric or gastroesophageal carcinoma: a meta-analysis and meta-regression
Authors
Keywords
-
Journal
Gastric Cancer
Volume 15, Issue 3, Pages 265-280
Publisher
Springer Nature
Online
2012-02-07
DOI
10.1007/s10120-011-0106-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gastric Cancer
- (2017) Jaffer A. Ajani et al. Journal of the National Comprehensive Cancer Network
- Gastric Cancer: A Primer on the Epidemiology and Biology of the Disease and an Overview of the Medical Management of Advanced Disease
- (2017) Manish A. Shah et al. Journal of the National Comprehensive Cancer Network
- Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial
- (2010) N C Tebbutt et al. BRITISH JOURNAL OF CANCER
- Gastric Cancer—An Enigmatic and Heterogeneous Disease
- (2010) Manish A. Shah JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Multicenter Phase III Comparison of Cisplatin/S-1 With Cisplatin/Infusional Fluorouracil in Advanced Gastric or Gastroesophageal Adenocarcinoma Study: The FLAGS Trial
- (2010) Jaffer A. Ajani et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
- (2010) Ying-Chun Shen et al. JOURNAL OF HEPATOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Population-based differences in treatment outcome following anticancer drug therapies
- (2010) Brigette BY Ma et al. LANCET ONCOLOGY
- A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction
- (2009) M. Moehler et al. ANNALS OF ONCOLOGY
- Race and ethnicity correlate with survival in patients with gastric adenocarcinoma
- (2009) J. Kim et al. ANNALS OF ONCOLOGY
- Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer
- (2009) A. F. C. Okines et al. ANNALS OF ONCOLOGY
- Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial
- (2009) Y.-K. Kang et al. ANNALS OF ONCOLOGY
- Geographic difference in survival outcome for advanced hepatocellular carcinoma: Implications on future clinical trial design
- (2009) Chiun Hsu et al. Contemporary Clinical Trials
- Understanding heterogeneity in meta-analysis: the role of meta-regression
- (2009) W. L. Baker et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics
- (2009) David R. Gandara et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2009) Eray Goekkurt et al. JOURNAL OF CLINICAL ONCOLOGY
- Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study
- (2009) Narikazu Boku et al. LANCET ONCOLOGY
- Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction
- (2008) M. Dank et al. ANNALS OF ONCOLOGY
- Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer
- (2008) B Sherrill et al. BRITISH JOURNAL OF CANCER
- A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer
- (2008) J-L Lee et al. BRITISH JOURNAL OF CANCER
- The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma
- (2008) Waddah B. Al-Refaie et al. CANCER
- Recommendations for the assessment of progression in randomised cancer treatment trials
- (2008) J.E. Dancey et al. EUROPEAN JOURNAL OF CANCER
- Potential Regional Differences for the Tolerability Profiles of Fluoropyrimidines
- (2008) Daniel G. Haller et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma with Fluorouracil, Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie
- (2008) Salah-Eddin Al-Batran et al. JOURNAL OF CLINICAL ONCOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started